共 20 条
[2]
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
[J].
ANNALS OF THE RHEUMATIC DISEASES,
2014, 73 (01)
:69-74
[6]
METHOTREXATE FOR RHEUMATOID-ARTHRITIS - SUGGESTED GUIDELINES FOR MONITORING LIVER TOXICITY
[J].
ARTHRITIS AND RHEUMATISM,
1994, 37 (03)
:316-328
[7]
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (09)
:2817-2829